Evaluating patient reported outcomes in routine practice of patients with rheumatoid arthritis treated with biological disease modifying anti rheumatic drugs (b-DMARDs)
Crossref DOI link: https://doi.org/10.1186/s40064-015-1247-5
Published Online: 2015-08-28
Published Print: 2015-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Boone, Niels W.
Teeuwisse, Patty
van der Kuy, Paul-Hugo
Janknegt, Rob
Landewé, Robert B. M.
Funding for this research was provided by:
Pfizer Netherlands (WI188344)
License valid from 2015-08-28